|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
3829R-2 |
| Symbol |
CG3829 |
Full Name |
CG3829 |
| CG No |
CG3829 |
Old CG No |
CG3829 |
| Synonyms |
CG3829 |
| Accession No (Link to NCBI) |
NM_138148.2 |
| Inserted Chr. |
ll |
| Insertional Mutation |
|
| Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Yu M, Ye H, De-Paula RB, Mangleburg CG, Wu T, Lee TV, Li Y, Duong D, Phillips B, Cruchaga C, Allen GI, Seyfried NT, Al-Ramahi I, Botas J, Shulman JM.<br> Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity.<br> PLoS Genet (2023) 19(5) e1010760
[
PubMed ID = 37200393
]
[
RRC reference
]
Carrera P, Odenthal J, Risse KS, Jung Y, Kuerschner L, Bülow MH.<br> The CD36 scavenger receptor Bez regulates lipid redistribution from fat body to ovaries in Drosophila.<br> Development (2024) 151(9)
[
PubMed ID = 38713014
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgGTCTACGCAATCAGGCTCAAA |
| Primer Seq. 3' |
aatctagaggtaccGAAAGCCTTCATGCGCTTAAC |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 gTCTACTGCA ATCAGGCTCA AAACCGCGAG CCAACATCCA AGGATATTGT GGAACTCTGA
0061 TAATGCTGGT GCGTAATGTT TTTGCTCTTT GTAATCAGCG TGACCGGATT TTTCGTAATG
0121 TGGTTTACCG AATATTACAA CAACACCATT CTGGAGAACC TGATCCTGGC CGAAAACTCG
0181 GATACCGCTA ATAGTTGGCT TAACCCTGAT CCTAAGTACG ACACTTTGCT AAAGGCTCAC
0241 ATTTTTCACT ACCCCAACAT CGATGACTAC TTAGCAGGGC GGGCAGATAA AATAAAGGTC
0301 GTGGATGTGG GACCTCTCAC CTACCAGGAA CACACTGTTA AAGATGAAGT TTCCTTTAAC
0361 AAAAATTTCA CTGTTAGCTT CAGGGACCGC AAGTCTTATA AGTTTCTCCC GGAGAAGTCG
0421 TCTATTGGGG AACACGAAGT GGTCAGGGTG CCCAATGTGC CGCTTATCTC TGCCGCCGGA
0481 CCAGTTAAGC GCATGAAGGC TTTC |
| in silico PCR Fragment |
0001 GTCTAC-GCA ATCAGGCTCA AAACCGCGAG CCAACATCCA AGGATAT--T GGAACTCTGA
0061 TAATGCTGG- GCGTAATGTT TTTGCTCTTT GTAATCAGCG TGACCGGATT TTTCGTAATG
0121 TGGTTTACCG AATATTACAA CAACACCATT CTGGAGAACC TGATCCTGGC CGAAAACTCG
0181 GATACCGCTA ATAGTTGGCT TAACCCTGAT CCTAAGTACG ACACTTTGCT AAAGGCTCAC
0241 ATTTTTCACT ACCCCAACAT CGATGACTAC TTAGCAGGGC GGGCAGATAA AATAAAGGTC
0301 GTGGATGTGG GACCTCTCAC CTACCAGGAA CACACTGTTA AAGATGAAGT TTCCTTTAAC
0361 AAAAATTTCA CTGTTAGCTT CAGGGACCGC AAGTCTTATA AGTTTCTCCC GGAAAAGTCG
0421 TCTATTGGGG AACACGAAGT GGTCAGGGTG CCCAATGTGC CGCTTATCTC TGCCGCCGGA
0481 CCAGTTAAGC GCATGAAGGC TTTC |
| Assemble Data |
<PRE>
3829R-2.IR_full 1 GTCTAC<span class="snp"><tt>T</tt></span>GCAATCAGGCTCAAAACCGCGAGCCAACATCCAAGGATAT<span class="snp"><tt>T</tt></span><span class="snp"><tt>G</tt></span>TGGAACTCTGA 60
||||||<span class="snp"><tt> </tt></span>||||||||||||||||||||||||||||||||||||||||<span class="snp"><tt> </tt></span><span class="snp"><tt> </tt></span>|||||||||||
3829R-2.in silico 1 GTCTAC<span class="snp"><tt>-</tt></span>GCAATCAGGCTCAAAACCGCGAGCCAACATCCAAGGATAT<span class="snp"><tt>-</tt></span><span class="snp"><tt>-</tt></span>TGGAACTCTGA 60
3829R-2.IR_full 61 TAATGCTGG<span class="snp"><tt>T</tt></span>GCGTAATGTTTTTGCTCTTTGTAATCAGCGTGACCGGATTTTTCGTAATG 120
|||||||||<span class="snp"><tt> </tt></span>||||||||||||||||||||||||||||||||||||||||||||||||||
3829R-2.in silico 61 TAATGCTGG<span class="snp"><tt>-</tt></span>GCGTAATGTTTTTGCTCTTTGTAATCAGCGTGACCGGATTTTTCGTAATG 120
3829R-2.IR_full 121 TGGTTTACCGAATATTACAACAACACCATTCTGGAGAACCTGATCCTGGCCGAAAACTCG 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3829R-2.in silico 121 TGGTTTACCGAATATTACAACAACACCATTCTGGAGAACCTGATCCTGGCCGAAAACTCG 180
3829R-2.IR_full 181 GATACCGCTAATAGTTGGCTTAACCCTGATCCTAAGTACGACACTTTGCTAAAGGCTCAC 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3829R-2.in silico 181 GATACCGCTAATAGTTGGCTTAACCCTGATCCTAAGTACGACACTTTGCTAAAGGCTCAC 240
3829R-2.IR_full 241 ATTTTTCACTACCCCAACATCGATGACTACTTAGCAGGGCGGGCAGATAAAATAAAGGTC 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3829R-2.in silico 241 ATTTTTCACTACCCCAACATCGATGACTACTTAGCAGGGCGGGCAGATAAAATAAAGGTC 300
3829R-2.IR_full 301 GTGGATGTGGGACCTCTCACCTACCAGGAACACACTGTTAAAGATGAAGTTTCCTTTAAC 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3829R-2.in silico 301 GTGGATGTGGGACCTCTCACCTACCAGGAACACACTGTTAAAGATGAAGTTTCCTTTAAC 360
3829R-2.IR_full 361 AAAAATTTCACTGTTAGCTTCAGGGACCGCAAGTCTTATAAGTTTCTCCCGGA<span class="snp"><tt>G</tt></span>AAGTCG 420
|||||||||||||||||||||||||||||||||||||||||||||||||||||<span class="snp"><tt> </tt></span>||||||
3829R-2.in silico 361 AAAAATTTCACTGTTAGCTTCAGGGACCGCAAGTCTTATAAGTTTCTCCCGGA<span class="snp"><tt>A</tt></span>AAGTCG 420
3829R-2.IR_full 421 TCTATTGGGGAACACGAAGTGGTCAGGGTGCCCAATGTGCCGCTTATCTCTGCCGCCGGA 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3829R-2.in silico 421 TCTATTGGGGAACACGAAGTGGTCAGGGTGCCCAATGTGCCGCTTATCTCTGCCGCCGGA 480
3829R-2.IR_full 481 CCAGTTAAGCGCATGAAGGCTTTC 504
||||||||||||||||||||||||
3829R-2.in silico 481 CCAGTTAAGCGCATGAAGGCTTTC 504
</PRE>
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
0 |
0 |
NM_138148.2 |
CG3829-RA (CG3829), mRNA |
| 0.41 |
2 |
4 |
3 |
2 |
NM_134765.2 |
CG14352-RA (CG14352), mRNA |
| 0 |
0 |
4 |
2 |
2 |
NM_170172.1 |
CG13636-RB, transcript variant B (CG13636), mRNA |
| 0 |
0 |
3 |
3 |
2 |
NR_002001.1 |
CR18748, mRNA |
| 0 |
0 |
3 |
3 |
2 |
NM_080268.1 |
CG8652-RA (Ugt37c1), mRNA |
| 0 |
0 |
2 |
2 |
3 |
NM_168450.1 |
CG6210-RB, transcript variant B (srt), mRNA |
| 0 |
0 |
2 |
2 |
3 |
NM_140188.2 |
CG6210-RA, transcript variant A (srt), mRNA |
| 0 |
0 |
1 |
4 |
2 |
NM_167717.1 |
CG32509-RA (CG32509), mRNA |
| 0 |
0 |
1 |
2 |
4 |
NM_135272.2 |
CG15818-RA (CG15818), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167530.1 |
CG9699-RA, transcript variant A (CG9699), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167534.1 |
CG9699-RF, transcript variant F (CG9699), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167532.1 |
CG9699-RD, transcript variant D (CG9699), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167533.1 |
CG9699-RE, transcript variant E (CG9699), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167531.1 |
CG9699-RB, transcript variant B (CG9699), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_132919.2 |
CG9699-RC, transcript variant C (CG9699), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_206766.1 |
CG9699-RG, transcript variant G (CG9699), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167985.1 |
CG14955-RB, transcript variant B (CG14955), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_167090.1 |
CG14438-RB, transcript variant B (CG14438), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_206593.1 |
CG1873-RC, transcript variant C (Ef1alpha100E), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_170570.1 |
CG1873-RB, transcript variant B (Ef1alpha100E), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_132120.1 |
CG14438-RA, transcript variant A (CG14438), mRNA |
| 0 |
0 |
0 |
4 |
3 |
NM_080250.2 |
CG6224-RA (dbo), mRNA |
| 0 |
0 |
0 |
4 |
2 |
NM_165591.1 |
CG11546-RC, transcript variant C (kermit), mRNA |
| 0 |
0 |
0 |
4 |
2 |
NM_143771.2 |
CG11546-RA, transcript variant A (kermit), mRNA |
| 0 |
0 |
0 |
4 |
2 |
NM_165592.1 |
CG11546-RD, transcript variant D (kermit), mRNA |
| 0 |
0 |
0 |
4 |
2 |
NM_165590.1 |
CG11546-RB, transcript variant B (kermit), mRNA |
| 0 |
0 |
0 |
3 |
7 |
NM_141738.3 |
CG6303-RA (Bruce), mRNA |
| 0 |
0 |
0 |
3 |
6 |
NM_168477.1 |
CG32092-RB (CG32092), mRNA |
| 0 |
0 |
0 |
3 |
6 |
NM_141986.2 |
CG7091-RA (CG7091), mRNA |
| 0 |
0 |
0 |
3 |
5 |
NM_143581.2 |
CG1715-RA (l(3)03670), mRNA |
|
|
Pathways (updated: 2024/04/26)
|
| KEGG Pathway |
|
|
|
